Literature DB >> 27278476

Influence of neoadjuvant chemoradiotherapy on the anal sphincter: ultrastructural damage may be critical.

Xiaoming Zhu1, Zheng Lou1, Haifeng Gong1, Ronggui Meng1, Liqiang Hao1, Wei Zhang2.   

Abstract

BACKGROUND: Neoadjuvant chemoradiotherapy (nCRT) in addition to the curative surgery has been the first of treatment for local advanced rectal cancer because of its benefits in local recurrence and sphincter-saving. However, its side effects on anorectal function have been recognized. The histopathological changes on internal anal sphincter (IAS) have been reported, but ultrastructure changes of external anal sphincter (EAS) are unknown. The aim of this study is to detect the alterations on the gross morphology of IAS and ultrastructure of EAS after nCRT.
METHODS: We collected 34 anal canal specimens of patients undergoing abdominoperineal resection (APR) prospectively. The length and thickness of IAS were measured with vernier caliper. The EAS was dissected for observation with transmission electron microscope (TEM).
RESULTS: Ten patients received nCRT (nCRT group) before surgery and 24 underwent APR directly (control group). The length and thickness of IAS in nCRT group were 22.68 ± 3.56 and 5.39 ± 0.74 mm, respectively. These parameters were 21.28 ± 3.62 and 5.35 ± 1.12 mm in control group, respectively. There were no significant differences in the length and thickness of IAS between the two groups (P>0.05). In nCRT group, the sarcomere and myofibril were arranged disorderly and parts of them that were filled with collagenous fiber, triads, and mitochondria were destroyed severely and the glycogenosome also distributed disorderly. Such alterations of EAS did not occur in control group.
CONCLUSIONS: The nCRT cannot change the gross morphology of IAS, while it induces serious damages to the ultrastructures of EAS which may adversely affect the anorectal function.

Entities:  

Keywords:  Anal sphincter; Neoadjuvant chemoradiotherapy; Rectal cancer; Ultrastructure

Mesh:

Year:  2016        PMID: 27278476     DOI: 10.1007/s00384-016-2618-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  15 in total

1.  Histologic analysis of the irradiated anal sphincter.

Authors:  Giovanna M Da Silva; Mariana Berho; Steven D Wexner; Jonathan Efron; Eric G Weiss; Juan J Nogueras; Anthony M Vernava; Jason T Connor; Pascal Gervaz
Journal:  Dis Colon Rectum       Date:  2003-11       Impact factor: 4.585

2.  Differences in tissue degeneration between preoperative chemotherapy and preoperative chemoradiotherapy for colorectal cancer.

Authors:  Yuji Nishizawa; Satoshi Fujii; Norio Saito; Masaaki Ito; Kentaro Nakajima; Atsushi Ochiai; Masanori Sugito; Akihiro Kobayashi; Yusuke Nishizawa
Journal:  Int J Colorectal Dis       Date:  2012-02-29       Impact factor: 2.571

3.  Faecal incontinence: A late side-effect of pelvic radiotherapy.

Authors:  S Putta; H J N Andreyev
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-09       Impact factor: 4.126

Review 4.  A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery.

Authors:  L Desnoo; S Faithfull
Journal:  Eur J Cancer Care (Engl)       Date:  2006-07       Impact factor: 2.520

5.  The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function.

Authors:  C F Kollmorgen; A P Meagher; B G Wolff; J H Pemberton; J A Martenson; D M Illstrup
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

6.  Correlation of clinical and manometric abnormalities of rectal function following chronic radiation injury.

Authors:  J S Varma; A N Smith; A Busuttil
Journal:  Br J Surg       Date:  1985-11       Impact factor: 6.939

7.  Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer.

Authors:  Masaaki Ito; Norio Saito; Masanori Sugito; Akihiro Kobayashi; Yusuke Nishizawa; Yoshiyuki Tsunoda
Journal:  Dis Colon Rectum       Date:  2009-01       Impact factor: 4.585

8.  Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.

Authors:  Cem Terzi; Aras Emre Canda; Ozgul Sagol; Koray Atila; Devrim Sonmez; Mehmet Fuzun; Ilknur B Gorken; Ilhan Oztop; Funda Obuz
Journal:  Int J Colorectal Dis       Date:  2007-09-06       Impact factor: 2.571

9.  Late side effects and quality of life after radiotherapy for rectal cancer.

Authors:  Kjersti Bruheim; Marianne G Guren; Eva Skovlund; Marianne J Hjermstad; Olav Dahl; Gunilla Frykholm; Erik Carlsen; Kjell Magne Tveit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-18       Impact factor: 7.038

10.  Early experience with postoperative adjuvant chemoradiation for rectal carcinoma: focus on morbidity.

Authors:  F C Chen; J R Mackay; R J Woods; B T Collopy; R J Fink; M J Guiney
Journal:  Aust N Z J Surg       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.